Drug Shortage Report for EPINEPHRINE INJECTION USP

Last updated on 2024-07-10 History
Report ID 228930
Drug Identification Number 00710814
Brand name EPINEPHRINE INJECTION USP
Common or Proper name EPINEPHRINE INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) EPINEPHRINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRACARDIAC INTRAVENOUS INTRACARDIAC
Packaging size 10 x 10mL
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-05-28
Estimated end date 2025-01-31
Actual end date
Shortage status Actual shortage
Updated date 2024-07-10
Company comments Epinephrine ampules remain available
Health Canada comments
Tier 3 Status Yes
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2024-07-10 French Compare
v10 2024-07-10 English Compare
v9 2024-06-27 French Compare
v8 2024-06-27 English Compare
v7 2024-06-26 French Compare
v6 2024-06-26 English Compare
v5 2024-06-19 English Compare
v4 2024-05-29 French Compare
v3 2024-05-29 English Compare
v2 2024-05-28 French Compare
v1 2024-05-28 English Compare

Showing 1 to 11 of 11